Marty Chavez is widely renowned as a trailblazer in bringing technology to Wall Street, revolutionizing how capital moves throughout the globe. He is a retired Partner at Goldman Sachs, having served in a variety of senior roles including Chief Information Officer, Chief Financial Officer, and global co-head of the firm’s Securities Division, and was a member of Goldman’s management committee. Previously, Marty was CEO and co-founder of Kiodex, acquired by Sungard in 2004, and Chief Technology Officer and co-founder of Quorum Software Systems. In addition to Recursion Pharma, Marty is an active board member for Paige, an AI-driven biomedical technology startup. Marty serves on the Board of Overseers of Harvard University (President), the Stanford Medicine Board of Fellows, and the Board of Trustees of the Institute for Advanced Study. He holds an A.B. (1985) magna cum laude in Biochemical Sciences and an S.M. (1985) in Computer Science from Harvard, and a Ph.D. (1990) in Medical Information Sciences from Stanford.